Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | ATM |
Variant | L546V |
Impact List | missense |
Protein Effect | no effect |
Gene Variant Descriptions | ATM L546V does not lie within any known functional domains of the Atm protein (UniProt.org). L546V demonstrates phosphorylation of Atm and downstream targets in response to irradiation to similar levels of wild-type protein in culture (PMID: 18573109, PMID: 19431188). |
Associated Drug Resistance | |
Category Variants Paths |
ATM mutant ATM L546V |
Transcript | NM_000051.4 |
gDNA | chr11:g.108251865C>G |
cDNA | c.1636C>G |
Protein | p.L546V |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_017017790.3 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
XM_047426981.1 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
XM_005271562 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
XM_011542843 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
XM_011542840.3 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
NM_000051.4 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
XM_011542843.2 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
XM_047426975.1 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
XM_017017790.2 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
XM_017017789.2 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
XM_011542843.3 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
XM_017017791.1 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
NM_001351834.1 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
XM_006718843.4 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
XM_005271562.6 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
XM_017017790 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
XM_006718843 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
XM_017017789 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
XM_011542840 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
XM_047426976.1 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
XM_017017791 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
XM_005271561 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
NM_000051.3 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
NM_001351834.2 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
XM_017017792 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
XM_011542840.4 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
XM_006718843.5 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
XM_017017792.2 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
XM_005271562.5 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
NM_000051 | chr11:g.108251865C>G | c.1636C>G | p.L546V | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|